After adjusting surgical procedure, vascular invasion and new tumor event after original treatment, MRPL27 was identified as independent risk factor for DFS in cholangiocarcinoma patients (HR = 5.72, p = 0.013, Table 3). Here, MRPL27 is linked to neoplasm.